Back
  1. Home
  3. Detailled Reference
No full text
Unpublished conference/Abstract (Scientific congresses and symposiums)
Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn’s disease: a Belgian multicentric refractory cohort.
Pavlidi, Anastasia; Verstockt, Bram; Vieujean, Sophie et al.
2025 • 37th edition of Belgian Week of Gastroenterology
Peer reviewed
Permalink
https://hdl.handle.net/2268/325922
 

Files (0)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
No document available.

Send to


Details


Disciplines :
Gastroenterology & hepatology
Author, co-author :
Pavlidi, Anastasia
Verstockt, Bram
Vieujean, Sophie  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie ; Université de Liège - ULiège > GIGA ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Desmedt, Valerie
Couturier, Filip
Rahier, Jean-Francois
Baert, Filip
Somers, Michael
Dewit, Olivier
Bossuyt, Peter
Hoyois, Alice
Holvoet, Tom
Ouziel, Romy
Willandt, Barbara
Lambrecht, Guy
Salame, Mika
Verreth, Annelies
Lenfant, Mathias
Franchimont, Denis
Cremer, Anneline
More authors (10 more) Less
Language :
English
Title :
Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn’s disease: a Belgian multicentric refractory cohort.
Publication date :
12 February 2025
Event name :
37th edition of Belgian Week of Gastroenterology
Event place :
Liège, Belgium
Event date :
February 12-14, 2025
By request :
Yes
Peer reviewed :
Peer reviewed
Available on ORBi :
since 27 December 2024

Statistics

Number of views
10 (1 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi